Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ZLAB

Stock Name	Zai Lab Ltd
Ticker	ZLAB(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US98887Q1040
LEI	549300P2UYQ9U5LY1T58

Show aggregate ZLAB holdings

News associated with ZLAB

Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) PT at $56.35: Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. […] - 2025-09-18 05:07:33
Notable Two Hundred Day Moving Average Cross - ZLAB: In trading on Thursday, shares of Zai Lab Ltd (Symbol: ZLAB) crossed below their 200 day moving average of $31.85, changing hands as low as $31.79 per share. Zai Lab Ltd shares are currently trading off about 1.5% on the day. The chart below shows the one year performance of Z - 2025-08-28 12:29:12
Zai Lab (NASDAQ:ZLAB) Now Covered by Jefferies Financial Group: Jefferies Financial Group initiated coverage on shares of Zai Lab (NASDAQ:ZLAB – Free Report) in a research report sent to investors on Monday. The brokerage issued a buy rating and a $52.00 price target on the stock. ZLAB has been the topic of a number of other reports. Citigroup restated a “buy” rating and set […] - 2025-08-26 03:04:48
Zai Lab (NASDAQ:ZLAB) Trading Down 5.9% on Insider Selling: Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report)’s share price traded down 5.9% during trading on Wednesday following insider selling activity. The company traded as low as $33.49 and last traded at $33.37. 309,987 shares changed hands during trading, a decline of 68% from the average session volume of 971,897 shares. The stock […] - 2025-08-22 02:00:52
US Bancorp DE Has $664,000 Stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB): US Bancorp DE lifted its stake in shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 213.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 18,365 shares of the company’s stock after buying an additional 12,500 shares during […] - 2025-08-11 05:24:58
Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Target Price at $54.28: Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month […] - 2025-07-28 02:15:01
Envestnet Asset Management Inc. Acquires 141,436 Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB): Envestnet Asset Management Inc. boosted its holdings in shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 379.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 178,714 shares of the company’s stock after purchasing an additional 141,436 […] - 2025-07-24 04:26:57
Kingsview Wealth Management LLC Grows Stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB): Kingsview Wealth Management LLC raised its stake in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Free Report) by 6.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,323 shares of the company’s stock after acquiring an additional 529 shares […] - 2025-07-23 06:09:01
Zai Lab (NASDAQ:ZLAB) Shares Gap Down – Time to Sell?: Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $36.01, but opened at $35.15. Zai Lab shares last traded at $34.59, with a volume of 89,278 shares traded. Analysts Set New Price Targets Several research firms have commented […] - 2025-07-20 05:23:02
Analysts Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Price Target at $54.28: Shares of Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The […] - 2025-07-03 02:21:01
Leerink Partners Boosts Zai Lab (NASDAQ:ZLAB) Price Target to $75.00: Zai Lab (NASDAQ:ZLAB – Get Free Report) had its target price hoisted by stock analysts at Leerink Partners from $73.00 to $75.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Leerink Partners’ target price would indicate a potential upside of 113.25% from the company’s previous […] - 2025-07-02 02:20:52
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) CEO Sells $855,160.97 in Stock: Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB – Get Free Report) CEO Ying Du sold 23,669 shares of the company’s stock in a transaction dated Thursday, June 26th. The shares were sold at an average price of $36.13, for a total value of $855,160.97. Following the sale, the chief executive officer now owns 514,982 shares in […] - 2025-06-30 05:09:07
Public Employees Retirement System of Ohio Has $484,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB): Public Employees Retirement System of Ohio lifted its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 20.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,480 shares of the company’s stock after buying an additional 3,179 shares during the quarter. Public Employees […] - 2025-06-05 06:14:51
Two Sigma Advisers LP Buys 4,200 Shares of Zai Lab Limited (NASDAQ:ZLAB): Two Sigma Advisers LP lifted its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 30.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,200 shares of the company’s stock after buying an additional 4,200 shares during the period. Two Sigma Advisers LP’s holdings in Zai Lab were worth […] - 2025-06-05 05:14:53
Balyasny Asset Management L.P. Sells 233,103 Shares of Zai Lab Limited (NASDAQ:ZLAB): Balyasny Asset Management L.P. reduced its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 90.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,508 shares of the company’s stock after selling 233,103 shares during the period. Balyasny […] - 2025-05-16 05:34:59
Hsbc Holdings PLC Purchases New Holdings in Zai Lab Limited (NASDAQ:ZLAB): Hsbc Holdings PLC acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 18,840 shares of the company’s stock, valued at approximately $493,000. Several other institutional investors have also added to or reduced their stakes in ZLAB. Geode Capital Management LLC raised […] - 2025-05-07 04:56:55
Envestnet Asset Management Inc. Invests $976,000 in Zai Lab Limited (NASDAQ:ZLAB): Envestnet Asset Management Inc. bought a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 37,278 shares of the company’s stock, valued at approximately $976,000. Several other hedge funds have also made changes to their positions in ZLAB. Pictet Asset Management Holding […] - 2025-05-02 04:15:08
Wells Fargo & Company MN Acquires 40,454 Shares of Zai Lab Limited (NASDAQ:ZLAB): Wells Fargo & Company MN boosted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 8,090.8% in the fourth quarter, HoldingsChannel reports. The fund owned 40,954 shares of the company’s stock after acquiring an additional 40,454 shares during the period. Wells Fargo & Company MN’s holdings in Zai Lab were worth […] - 2025-04-30 04:41:02
Bank of Montreal Can Has $442,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB): Bank of Montreal Can boosted its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 21.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,893 shares of the company’s stock after buying an additional 2,993 shares during the quarter. Bank of Montreal Can’s holdings in Zai Lab were worth $442,000 at […] - 2025-04-23 04:56:51
Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by Fmr LLC: Fmr LLC raised its position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 749.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,475,505 shares of the company’s stock after purchasing an additional 4,830,646 shares during the period. Fmr LLC owned about 5.00% of Zai Lab worth […] - 2025-04-14 06:28:49
Russell Investments Group Ltd. Sells 25,938 Shares of Zai Lab Limited (NASDAQ:ZLAB): Russell Investments Group Ltd. lessened its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 231,694 shares of the company’s stock after selling 25,938 shares during the quarter. Russell Investments […] - 2025-04-14 04:54:58
Zai Lab (NASDAQ:ZLAB) Trading Down 7.1% After Insider Selling: Shares of Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) were down 7.1% on Wednesday following insider selling activity. The stock traded as low as $24.74 and last traded at $25.14. Approximately 710,767 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 966,621 shares. The stock had previously […] - 2025-04-11 02:16:49
63,909 Shares in Zai Lab Limited (NASDAQ:ZLAB) Acquired by Zurcher Kantonalbank Zurich Cantonalbank: Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 63,909 shares of the company’s stock, valued at approximately $1,674,000. Other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. […] - 2025-03-18 06:54:52
Cantor Fitzgerald Upgrades Zai Lab (NASDAQ:ZLAB) to “Strong-Buy”: Cantor Fitzgerald upgraded shares of Zai Lab (NASDAQ:ZLAB – Free Report) to a strong-buy rating in a report released on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Zai Lab’s FY2025 earnings at ($1.38) EPS. Separately, Bank of America reissued a “neutral” rating and set a $36.10 price objective (up from $29.00) on shares of […] - 2025-03-07 04:30:47
Bank of America Reiterates Neutral Rating for Zai Lab (NASDAQ:ZLAB): Zai Lab (NASDAQ:ZLAB – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Bank of America in a note issued to investors on Monday, MarketBeat reports. They presently have a $36.10 price objective on the stock, up from their previous price objective of $29.00. Bank of America‘s target price would suggest […] - 2025-03-05 04:33:01
Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB): Principal Financial Group Inc. acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,762,954 shares of the company’s stock, valued at approximately $46,172,000. A number of other institutional investors and hedge funds have also modified their holdings of ZLAB. Y Intercept […] - 2025-02-21 07:49:08
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald: Zai Lab (NASDAQ:ZLAB – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Separately, JPMorgan Chase & Co. increased their price target on Zai Lab from $38.00 to $44.00 and gave the stock an “overweight” rating in a research report on Monday, […] - 2025-02-07 04:28:44

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ZLAB holdings

Date	Number of ZLAB Shares Held	Base Market Value of ZLAB Shares	Local Market Value of ZLAB Shares	Change in ZLAB Shares Held	Change in ZLAB Base Value	Current Price per ZLAB Share Held	Previous Price per ZLAB Share Held
2025-11-11 (Tuesday)	30,701	USD 675,422	USD 675,422	0	USD 3,377	USD 22	USD 21.89
2025-11-10 (Monday)	30,701	USD 672,045	USD 672,045	79	USD 1,423	USD 21.89	USD 21.9
2025-11-07 (Friday)	30,622	USD 670,622	USD 670,622	0	USD -38,277	USD 21.9	USD 23.15
2025-11-06 (Thursday)	30,622	USD 708,899	USD 708,899	79	USD -48,567	USD 23.15	USD 24.8
2025-11-05 (Wednesday)	30,543	USD 757,466	USD 757,466	0	USD -33,292	USD 24.8	USD 25.89
2025-11-04 (Tuesday)	30,543	USD 790,758	USD 790,758	79	USD -24,154	USD 25.89	USD 26.75
2025-11-03 (Monday)	30,464	USD 814,912	USD 814,912	0	USD 18,888	USD 26.75	USD 26.13
2025-10-31 (Friday)	30,464	USD 796,024	USD 796,024	0	USD 18,583	USD 26.13	USD 25.52
2025-10-30 (Thursday)	30,464	USD 777,441	USD 777,441	395	USD 16,094	USD 25.52	USD 25.32
2025-10-29 (Wednesday)	30,069	USD 761,347	USD 761,347	158	USD 1,308	USD 25.32	USD 25.41
2025-10-28 (Tuesday)	29,911	USD 760,039	USD 760,039	0	USD -27,817	USD 25.41	USD 26.34
2025-10-27 (Monday)	29,911	USD 787,856	USD 787,856	0	USD 598	USD 26.34	USD 26.32

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ZLAB by Blackrock for IE00BDZVHG35

Show aggregate share trades of ZLAB

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 79 21.890* 31.45
2025-11-06 BUY 79 23.150* 31.54
2025-11-04 BUY 79 25.890* 31.61
2025-10-30 BUY 395 26.475 25.450 25.553 USD 10,093 31.70
2025-10-29 BUY 158 25.320 25.650 25.617 USD 4,047 31.74
2025-10-22 SELL -316 29.090 29.490 29.450 USD -9,306 31.87 Profit of 766 on sale
2025-10-20 BUY 158 28.740 28.930 28.911 USD 4,568 31.91
2025-10-17 BUY 394 28.290 28.830 28.776 USD 11,338 31.93
2025-10-15 BUY 624 29.390 30.180 30.101 USD 18,783 31.94
2025-10-03 BUY 553 33.750 34.070 34.038 USD 18,823 31.95
2025-10-02 BUY 79 33.850 34.720 34.633 USD 2,736 31.94
2025-09-30 BUY 158 33.890 34.630 34.556 USD 5,460 31.91
2025-09-26 BUY 158 31.620 32.000 31.962 USD 5,050 31.91
2025-09-25 BUY 158 31.630 32.120 32.071 USD 5,067 31.91
2025-09-18 BUY 99 33.000 33.200 33.180 USD 3,285 31.90
2025-09-17 BUY 300 32.580 32.960 32.922 USD 9,877 31.90
2025-07-17 SELL -198 36.010 36.530 36.478 USD -7,223 31.84 Loss of -919 on sale
2025-07-11 SELL -792 32.730 33.530 33.450 USD -26,492 31.77 Loss of -1,330 on sale
2025-07-02 BUY 5,445 35.490 35.710 35.688 USD 194,321 31.67
2025-06-25 BUY 198 36.960 37.100 37.086 USD 7,343 31.56
2025-06-20 SELL -927 34.550 35.760 35.639 USD -33,037 31.46 Loss of -3,872 on sale
2025-06-11 BUY 206 41.400 41.440 41.436 USD 8,536 31.03
2025-06-10 BUY 206 40.000 40.160 40.144 USD 8,270 30.97
2025-06-04 SELL -103 36.080 36.360 36.332 USD -3,742 30.77 Loss of -573 on sale
2025-04-23 BUY 102 33.620 34.590 34.493 USD 3,518 30.71
2025-04-10 SELL -824 24.320 28.730 28.289 USD -23,310 30.85 Profit of 2,107 on sale
2025-04-08 SELL -102 27.070 30.260 29.941 USD -3,054 30.93 Profit of 101 on sale
2025-04-07 SELL -102 28.805 30.910 30.699 USD -3,131 30.96 Profit of 26 on sale
2025-04-04 SELL -515 31.770 34.980 34.659 USD -17,849 30.95 Loss of -1,911 on sale
2025-04-01 BUY 428 37.290 38.700 38.559 USD 16,503 30.81
2025-03-31 SELL -309 36.140 36.920 36.842 USD -11,384 30.74 Loss of -1,885 on sale
2025-03-21 BUY 6,198 35.090 35.800 35.729 USD 221,448 30.36
2025-03-14 SELL -1,312 38.200 39.610 39.469 USD -51,783 29.82 Loss of -12,657 on sale
2025-03-07 SELL -164 36.420 37.990 37.833 USD -6,205 29.38 Loss of -1,386 on sale
2025-03-04 SELL -82 34.000 34.080 34.072 USD -2,794 29.11 Loss of -407 on sale
2025-02-25 BUY 164 33.910 35.240 35.107 USD 5,758 28.69
2025-02-19 SELL -82 30.970 31.690 31.618 USD -2,593 28.44 Loss of -261 on sale
2025-02-13 BUY 246 28.820 30.000 29.882 USD 7,351 28.36
2025-02-12 BUY 82 27.970 28.030 28.024 USD 2,298 28.37
2025-02-11 BUY 328 27.060 27.410 27.375 USD 8,979 28.39
2024-12-30 SELL -2,512 26.470 26.770 26.740 USD -67,171 29.09 Profit of 5,906 on sale
2024-11-18 SELL -1,323 25.170 26.910 26.736 USD -35,372 30.58 Profit of 5,087 on sale
2024-11-08 SELL -88 30.620 31.240 31.178 USD -2,744 30.69 Loss of -43 on sale
2024-10-21 SELL -89 28.000 28.160 28.144 USD -2,505 0.00 Loss of -2,505 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	79			21.890*		31.45
2025-11-06	BUY	79			23.150*		31.54
2025-11-04	BUY	79			25.890*		31.61
2025-10-30	BUY	395	26.475	25.450	25.553	USD 10,093	31.70
2025-10-29	BUY	158	25.320	25.650	25.617	USD 4,047	31.74
2025-10-22	SELL	-316	29.090	29.490	29.450	USD -9,306	31.87 Profit of 766 on sale
2025-10-20	BUY	158	28.740	28.930	28.911	USD 4,568	31.91
2025-10-17	BUY	394	28.290	28.830	28.776	USD 11,338	31.93
2025-10-15	BUY	624	29.390	30.180	30.101	USD 18,783	31.94
2025-10-03	BUY	553	33.750	34.070	34.038	USD 18,823	31.95
2025-10-02	BUY	79	33.850	34.720	34.633	USD 2,736	31.94
2025-09-30	BUY	158	33.890	34.630	34.556	USD 5,460	31.91
2025-09-26	BUY	158	31.620	32.000	31.962	USD 5,050	31.91
2025-09-25	BUY	158	31.630	32.120	32.071	USD 5,067	31.91
2025-09-18	BUY	99	33.000	33.200	33.180	USD 3,285	31.90
2025-09-17	BUY	300	32.580	32.960	32.922	USD 9,877	31.90
2025-07-17	SELL	-198	36.010	36.530	36.478	USD -7,223	31.84 Loss of -919 on sale
2025-07-11	SELL	-792	32.730	33.530	33.450	USD -26,492	31.77 Loss of -1,330 on sale
2025-07-02	BUY	5,445	35.490	35.710	35.688	USD 194,321	31.67
2025-06-25	BUY	198	36.960	37.100	37.086	USD 7,343	31.56
2025-06-20	SELL	-927	34.550	35.760	35.639	USD -33,037	31.46 Loss of -3,872 on sale
2025-06-11	BUY	206	41.400	41.440	41.436	USD 8,536	31.03
2025-06-10	BUY	206	40.000	40.160	40.144	USD 8,270	30.97
2025-06-04	SELL	-103	36.080	36.360	36.332	USD -3,742	30.77 Loss of -573 on sale
2025-04-23	BUY	102	33.620	34.590	34.493	USD 3,518	30.71
2025-04-10	SELL	-824	24.320	28.730	28.289	USD -23,310	30.85 Profit of 2,107 on sale
2025-04-08	SELL	-102	27.070	30.260	29.941	USD -3,054	30.93 Profit of 101 on sale
2025-04-07	SELL	-102	28.805	30.910	30.699	USD -3,131	30.96 Profit of 26 on sale
2025-04-04	SELL	-515	31.770	34.980	34.659	USD -17,849	30.95 Loss of -1,911 on sale
2025-04-01	BUY	428	37.290	38.700	38.559	USD 16,503	30.81
2025-03-31	SELL	-309	36.140	36.920	36.842	USD -11,384	30.74 Loss of -1,885 on sale
2025-03-21	BUY	6,198	35.090	35.800	35.729	USD 221,448	30.36
2025-03-14	SELL	-1,312	38.200	39.610	39.469	USD -51,783	29.82 Loss of -12,657 on sale
2025-03-07	SELL	-164	36.420	37.990	37.833	USD -6,205	29.38 Loss of -1,386 on sale
2025-03-04	SELL	-82	34.000	34.080	34.072	USD -2,794	29.11 Loss of -407 on sale
2025-02-25	BUY	164	33.910	35.240	35.107	USD 5,758	28.69
2025-02-19	SELL	-82	30.970	31.690	31.618	USD -2,593	28.44 Loss of -261 on sale
2025-02-13	BUY	246	28.820	30.000	29.882	USD 7,351	28.36
2025-02-12	BUY	82	27.970	28.030	28.024	USD 2,298	28.37
2025-02-11	BUY	328	27.060	27.410	27.375	USD 8,979	28.39
2024-12-30	SELL	-2,512	26.470	26.770	26.740	USD -67,171	29.09 Profit of 5,906 on sale
2024-11-18	SELL	-1,323	25.170	26.910	26.736	USD -35,372	30.58 Profit of 5,087 on sale
2024-11-08	SELL	-88	30.620	31.240	31.178	USD -2,744	30.69 Loss of -43 on sale
2024-10-21	SELL	-89	28.000	28.160	28.144	USD -2,505	0.00 Loss of -2,505 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ZLAB

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	80,828	0	171,440	47.1%
2025-09-18	68,548	0	171,979	39.9%
2025-09-17	64,119	7	122,548	52.3%
2025-09-16	80,652	9	211,177	38.2%
2025-09-15	79,343	38	154,067	51.5%
2025-09-12	219,474	0	413,796	53.0%
2025-09-11	358,908	5,386	996,390	36.0%
2025-09-10	281,868	3,417	879,391	32.1%
2025-09-09	166,792	0	435,026	38.3%
2025-09-08	178,725	41	654,600	27.3%
2025-09-05	169,302	0	368,854	45.9%
2025-09-04	135,798	3	279,716	48.5%
2025-09-03	178,946	0	436,405	41.0%
2025-09-02	63,821	100	117,435	54.3%
2025-08-29	78,215	0	142,160	55.0%
2025-08-28	129,230	6	238,288	54.2%
2025-08-27	125,953	0	313,235	40.2%
2025-08-26	55,771	0	100,132	55.7%
2025-08-25	68,641	0	116,866	58.7%
2025-08-22	65,412	0	188,853	34.6%
2025-08-21	80,332	0	209,967	38.3%
2025-08-20	118,560	0	278,412	42.6%
2025-08-19	65,510	0	107,845	60.7%
2025-08-18	66,349	0	103,601	64.0%
2025-08-15	59,556	0	98,556	60.4%
2025-08-14	57,235	0	94,539	60.5%
2025-08-13	64,643	0	126,713	51.0%
2025-08-12	58,482	10	138,026	42.4%
2025-08-11	71,142	0	153,887	46.2%
2025-08-08	137,274	8,142	223,989	61.3%
2025-08-07	333,549	4,930	486,714	68.5%
2025-08-06	150,129	0	226,109	66.4%
2025-08-05	178,135	0	237,199	75.1%
2025-08-04	76,989	0	118,898	64.8%
2025-08-01	169,831	30	230,452	73.7%
2025-07-31	129,616	700	181,920	71.2%
2025-07-30	115,170	0	189,784	60.7%
2025-07-29	236,864	7	672,237	35.2%
2025-07-28	263,521	0	497,158	53.0%
2025-07-25	121,374	98	277,616	43.7%
2025-07-24	84,893	0	236,642	35.9%
2025-07-23	213,787	0	456,171	46.9%
2025-07-22	482,814	0	850,745	56.8%
2025-07-21	182,448	106	451,173	40.4%
2025-07-18	147,339	883	271,678	54.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE